PPARD and obesity due to melanocortin 4 receptor deficiency: Mice with overexpression of this receptor show resistance to obesity and a phenotype of marathon runners, in contrast with the tendency to overweight exhibited by knocked-out mice Hence, PPARβ could have a promising potential for the treatment of obesity, T2DM and cardiovascular disease.